Concord Medical Services Holding Ltd. ADR Stock

$8.46

0.15% yesterday

NYSE, May 20, 10:10 pm CET

ISIN

US2062771058

Symbol

CCM

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

Concord Medical Services Holding Ltd. ADR Stock price

$8.46

-5.54 39.55% 5Y

NYSE, Closing price Tue, May 20 2025

+0.01 0.15%

ISIN

US2062771058

Symbol

CCM

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Health service provider

Key metrics

Market capitalization	$23.83m
Enterprise Value	$1.05b
P/E (TTM) P/E ratio	negative
EV/Sales (TTM) EV/Sales	19.60
P/S ratio (TTM) P/S ratio	0.45
P/B ratio (TTM) P/B ratio	negative
Revenue growth (TTM) Revenue growth	-29.82%
Revenue (TTM) Revenue	$53.33m
EBIT (operating result TTM) EBIT	$-73.99m
EPS (TTM) EPS	$-9.83
Short interest	3.01%

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Get Started for Free Today

Concord Medical Services Holding Ltd. ADR Stock Analysis

Unlock Scores for Free

??

Financial data from Concord Medical Services Holding Ltd. ADR

Income Statement P&L | Balance Sheet | Cash Flow

TTM Annually

Dec '24		+/- %
Revenue	53 53	30% 30% 100%
- Direct Costs	64 64	26% 26% 121%
Gross Profit	-11 -11	2% 2% -21%
- Selling and Administrative Expenses	45 45	23% 23% 84%
- Research and Development Expense	- -	- -
EBITDA	-56 -56	18% 18% -105%
- Depreciation and Amortization	18 18	0% 0% 34%
EBIT (Operating Income) EBIT	-74 -74	13% 13% -139%
Net Profit	-43 -43	3% 3% -80%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Concord Medical Services Holding Ltd. ADR Stock News

Neutral

PRNewsWire

●

25 days ago

Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

BEIJING , April 25, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "Annual Report") with the U.S. Securities and Exchange...

Neutral

PRNewsWire

●

4 months ago

Concord Medical Announces Result of 2024 Annual General Meeting

BEIJING , Jan. 6, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it held its 2024 annual general meeting of shareholders on December 27, 2024. At the meeting, the shareholders resolved by special resolution tha...

Neutral

PRNewsWire

●

5 months ago

Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

BEIJING , Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that the National Medical Products Administration of the People's Republic of China has granted approval to the application for the Registration Certi...

Company Profile

Concord Medical Services Holding Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. It provides radiotherapy and diagnostic equipment leasing services to hospitals; and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals, It operates through Network Business and Hospital Business segments. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Head office	Cayman Islands
CEO	Jianyu Yang
Employees	595
Founded	2007
Website	ir.ccm.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now